<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2604-1227</journal-id>
<journal-title><![CDATA[Revista mexicana de oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. oftalmol]]></abbrev-journal-title>
<issn>2604-1227</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Oftalmología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2604-12272024000100004</article-id>
<article-id pub-id-type="doi">10.24875/rmo.m25000269</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Linfoma orbitario de rápida progresión secundario a VIH no controlado: reporte de un caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Rapidly progressing orbital lymphoma secondary to uncontrolled HIV infection: case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Noriega]]></surname>
<given-names><![CDATA[Stephanie]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Restrepo-Jiménez]]></surname>
<given-names><![CDATA[Paula]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ruiz-Robles]]></surname>
<given-names><![CDATA[Luis A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Pontificia Universidad Javeriana Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Universitario San Ignacio Unidad de Oftalmología ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2024</year>
</pub-date>
<volume>98</volume>
<numero>1</numero>
<fpage>20</fpage>
<lpage>24</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2604-12272024000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2604-12272024000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2604-12272024000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Reportar un caso de linfoma orbitario de rápida progresión secundario a infección por virus de la inmunodeficiencia humana (VIH) no controlada y revisar las características de esta afección. Se presenta el caso de una paciente de 28 años con antecedente de infección por VIH quien consultó por un cuadro clínico consistente en edema palpebral asociado a proptosis ocular.  Observaciones: Al examen oftalmológico debutó con limitación para los movimientos extraoculares, marcado abotagamiento palpebral y quemosis conjuntival. Se solicitaron estudios imagenológicos con evidencia de compromiso orbitario bilateral sugestivo de linfoma. Por medio del análisis patológico de una biopsia orbitaria se confirmó el diagnóstico de linfoma B de alto grado, para lo cual se inició tratamiento con quimioterapia, con buena respuesta sistémica y oftalmológica.  Conclusiones e importancia: El linfoma no Hodgkin es una de las enfermedades definitorias de sida y representa la segunda neoplasia más común en pacientes con este diagnóstico. Su incidencia es especialmente alta en poblaciones inmunodeprimidas con recuentos bajos de CD4. Por tanto, el diagnóstico temprano y el tratamiento oportuno son cruciales para reducir la gravedad de la enfermedad y mejorar la supervivencia de los pacientes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: To report a case of rapidly progressing orbital lymphoma secondary to uncontrolled human immunodeficiency virus (HIV) infection and to review the characteristics of this condition. We present the case of a 28-year-old female patient with a history of HIV infection who presented with a clinical picture consisting of eyelid edema associated with ocular proptosis.  Observations: On ophthalmologic examination, the patient exhibited restricted extraocular movements, marked eyelid swelling, and conjunctival chemosis. Imaging studies revealed bilateral orbital involvement suggestive of lymphoma. A pathological analysis of an orbital biopsy confirmed the diagnosis of high-grade B-cell lymphoma, for which chemotherapy was initiated with good systemic and ophthalmologic response.  Conclusions and importance: Non-Hodgkin lymphoma is one of the AIDS-defining illnesses and represents the second most common neoplasm in patients with this diagnosis. Its incidence is particularly high in immunosuppressed populations with low CD4 counts. Therefore, early diagnosis and timely treatment are crucial to reduce disease severity and improve patient survival.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Oftalmología]]></kwd>
<kwd lng="es"><![CDATA[Linfoma]]></kwd>
<kwd lng="es"><![CDATA[VIH]]></kwd>
<kwd lng="es"><![CDATA[Neoplasia]]></kwd>
<kwd lng="es"><![CDATA[Inmunosupresión]]></kwd>
<kwd lng="en"><![CDATA[Ophthalmology]]></kwd>
<kwd lng="en"><![CDATA[Lymphoma]]></kwd>
<kwd lng="en"><![CDATA[HIV]]></kwd>
<kwd lng="en"><![CDATA[Neoplasia]]></kwd>
<kwd lng="en"><![CDATA[Immunosuppression]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>Diccionario del Cáncer del NCI</collab>
<source><![CDATA[Linfoma]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández-Ramírez]]></surname>
<given-names><![CDATA[RU]]></given-names>
</name>
<name>
<surname><![CDATA[Shiels]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Dubrow]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Engels]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer risk in HIV-infected people in the USA from 1996 to 2012:a population-based, registry-linkage study]]></article-title>
<source><![CDATA[Lancet HIV]]></source>
<year>2017</year>
<volume>4</volume>
<page-range>e495-504</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuervo]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
<name>
<surname><![CDATA[Cortès]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Gualtero]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neoplasias definitorias de SIDA]]></article-title>
<source><![CDATA[Infectio]]></source>
<year>2006</year>
<volume>10</volume>
<page-range>289-93</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fink]]></surname>
<given-names><![CDATA[VI]]></given-names>
</name>
<name>
<surname><![CDATA[Shepherd]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Cesar]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Krolewiecki]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wehbe]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cortés]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer in HIV-Infected Persons From the Caribbean, Central and South America]]></article-title>
<source><![CDATA[J Acquir Immune Defic Syndr]]></source>
<year>2011</year>
<volume>56</volume>
<page-range>467-73</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spina]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carbone]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gloghini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Serraino]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Berretta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tirelli]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hodgkin's disease in patients with HIV infection]]></article-title>
<source><![CDATA[Adv Hematol]]></source>
<year>2011</year>
<volume>2011</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bowling]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[Kanski Oftalmología clínica:un enfoque sistemático]]></source>
<year>2016</year>
<edition>8.ªed</edition>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosales Torres]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[León Acosta]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Pila Pérez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfoma primario de la órbita Informe de un caso]]></article-title>
<source><![CDATA[Mediciego]]></source>
<year>2023</year>
<volume>29</volume>
<page-range>19</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojas Bilbao]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Nesprias]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pulerob]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Giménez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zerga]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chirife]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfomas de la órbita y anexos oculares:correlación clínico patológica de 25 casos]]></article-title>
<source><![CDATA[Medicina (Buenos Aires)]]></source>
<year>2010</year>
<volume>70</volume>
<page-range>333-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bartalena]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Kahaly]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Baldeschi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dayan]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Eckstein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Marcocci]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The 2021 European Group on Graves'orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves'orbitopathy]]></article-title>
<source><![CDATA[Eur J Endocrinol]]></source>
<year>2021</year>
<volume>185</volume>
<page-range>G43-67</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coy Villamil]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Orbitopatia tiroidea:conceptos básicos y diagnóstico clínico]]></article-title>
<source><![CDATA[Revista Colombiana de Endocrinología, Diabetes y Metabolismo]]></source>
<year>2019</year>
<volume>6</volume>
<numero>Supl 1</numero>
<issue>Supl 1</issue>
<page-range>26-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coy Villamil]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Orbitopatia tiroidea:herramientas e imágenes en el diagnóstico]]></article-title>
<source><![CDATA[Revista Colombiana de Endocrinología, Diabetes y Metabolismo]]></source>
<year>2019</year>
<volume>6</volume>
<numero>Supl 1</numero>
<issue>Supl 1</issue>
<page-range>32-3</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ayers]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Medeiros]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bond]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Maddocks]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Torka]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2020</year>
<volume>126</volume>
<page-range>293-303</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcia-Manero]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kantarjian]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The hyper-CVAD regimen in adult acute lymphocytic leukemia]]></article-title>
<source><![CDATA[Hematol Oncol Clin North Am]]></source>
<year>2000</year>
<volume>14</volume>
<page-range>1381-96</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wyen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jensen]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hentrich]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Siehl]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sabranski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Esser]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of AIDS-related lymphomas:rituximab is beneficial even in severely immunosuppressed patients]]></article-title>
<source><![CDATA[AIDS]]></source>
<year>2012</year>
<volume>26</volume>
<page-range>457-64</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<collab>World Health Organization</collab>
<article-title xml:lang=""><![CDATA[WHO clinical staging of HIV disease in adults, adolescents and children]]></article-title>
<source><![CDATA[En:Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection:recommendations for a public health approach]]></source>
<year>2016</year>
<edition>2 nd ed</edition>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Faderl]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[O'Brien]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bueso-Ramos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cortes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Manero]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2006</year>
<volume>106</volume>
<page-range>1569-80</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
